Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Methylchloroisothiazolinone" patented technology

Methylchloroisothiazolinone, also referred to as MCI, is a preservative with antibacterial and antifungal effects within the group of isothiazolinones. It is effective against gram-positive and gram-negative bacteria, yeast, and fungi.

A pretreatment device for raw materials in the production of high-purity Kathon

This utility model discloses a pretreatment device for raw materials in the production of high-purity Kathon, relating to the field of Kathon production technology. The inlet of an ultrasonic reactor is connected via pipelines to a methylchloroisothiazolinone raw material tank and a deionized water tank. The outlet of the ultrasonic reactor is connected via a screw pump to a ceramic membrane device. The liquid phase outlet of the ceramic membrane device is connected via pipelines to a distillation column. The top gas phase outlet of the distillation column is connected via pipelines to a light component tank, an organic solvent tank, and a purified methylchloroisothiazolinone tank. This device achieves effective separation and purification of different components, improving product purity, while simultaneously recovering organic solvents and reducing production costs.
Owner:SHANDONG YUBIN NEW MATERIALS CO LTD

A compound preparation for nourishing and maintaining the vagina and pelvic floor muscles by using plant fermented lactic acid bacteria lysate

This invention discloses a compound preparation of plant-fermented lactic acid bacteria lysate for nourishing and protecting the vaginal pelvic floor muscles. By weight, it comprises the following components: kidney bean-honeysuckle fruit compound ferment: 4-8 parts; pomegranate peel-derived lactic acid bacteria lysate: 5-9 parts; bamboo fungus mycelium extract: 3-7 parts; compound sophorolipid: 6-8 parts; sodium hyaluronate: 2-5 parts; total glycosides of Centella asiatica: 1-3 parts; glycerin: 5-10 parts; lactic acid: 1-2 parts; purified... Water: 36-45 parts; Carbomer 940: 2-4 parts; Trehalose: 1-3 parts; Chitosan: 1-3 parts; Methylchloroisothiazolinone: 0.1-0.3 parts; Sodium hydroxide: 0.1-0.2 parts; This invention can regulate the vaginal microecological balance, nourish the vaginal mucosa, enhance the toughness of pelvic floor muscle fibers, and promote the repair of pelvic floor muscle damage, solving the technical problems of existing preparations having single function, weak targeted pelvic floor muscle care, and easy disruption of the vaginal microecology.
Owner:YUANSHENGMEI (SHENYANG) REGENERATIVE MEDICINE TECHNOLOGY CO LTD